Sign In
Buy KVUE
$16.83
-0.490 (-2.83%)
At Close: Jun 03, 2026
Kimberly-Clark to acquire Kenvue in $48.7 billion deal
06:36am, Monday, 03'rd Nov 2025
Kimberly-Clark said on Monday it will acquire Tylenol maker Kenvue in a deal valued at about $48.7 billion.
Kenvue Reports Third Quarter 2025 Results
06:30am, Monday, 03'rd Nov 2025
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced financial results for the third quarter ended September 28, 2025. “Throughout the third quarter, our team remained focused on
Kimberly-Clark to Acquire Kenvue, Creating a $32 Billion Global Health and Wellness Leader
06:30am, Monday, 03'rd Nov 2025
Combines Highly Complementary and Strategically Aligned Consumer Offerings, Including 10 Iconic Billion-Dollar Brands, That Will Provide Preferred Solutions Through Every Stage of Life Applies Kimberl
Will President Trump's Tylenol Claims Hurt These 2 Leading Pharmaceutical Stocks?
06:15am, Monday, 03'rd Nov 2025
There were rumors that the FDA was going to warn pregnant women against using Tylenol. When the news finally hit, Tylenol maker Kenvue's stock had already fallen a great deal.
Financial Survey: Kenvue (NYSE:KVUE) vs. Krispy Kreme (NASDAQ:DNUT)
01:32am, Sunday, 02'nd Nov 2025
Kenvue (NYSE: KVUE - Get Free Report) and Krispy Kreme (NASDAQ: DNUT - Get Free Report) are both consumer staples companies, but which is the superior investment? We will compare the two companies bas
These 3 Dividend Stocks Yield More Than 5% and Have Payout Ratios Over 100%. Are Dividend Cuts Coming?
07:05am, Saturday, 01'st Nov 2025
Investors can look at a company's payout ratio to help gauge whether its dividend is sustainable. In some industries, however, companies use adjusted-profit calculations to assess the safety of their
Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
04:27pm, Thursday, 30'th Oct 2025
Risk-averse investors may prefer focusing on investment targets with broad approval from Wall Street analysts in the form of Buy ratings. However, sometimes attractive prospects may also be found in H
Earnings Preview: Kenvue (KVUE) Q3 Earnings Expected to Decline
11:06am, Thursday, 30'th Oct 2025
Kenvue (KVUE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Kenvue: Temporary Headwinds Don't Derail Its Consumer Health Dominance And 5.5% Dividend Yield
02:30pm, Wednesday, 29'th Oct 2025
Kenvue offers a defensive, dividend-rich investment opportunity after a 34% stock decline, trading at a 10% discount to peers. KVUE's 5.5% dividend yield and strong operating margins make it attractiv
US health chief says not enough data to show Tylenol causes autism, but still advises caution
02:08pm, Wednesday, 29'th Oct 2025
U.S. Health Secretary Robert F. Kennedy Jr. on Wednesday said there is not enough evidence to show that Kenvue's pain medicine Tylenol definitively causes autism, but said that it should still be used
Kenvue Declares Quarterly Cash Dividend
06:45am, Wednesday, 29'th Oct 2025
SUMMIT, N.J.--(BUSINESS WIRE)--Kenvue Inc. (NYSE: KVUE) today announced that its Board of Directors declared a quarterly dividend of $0.2075 per share on its common stock. The quarterly dividend is pa
Analyzing Kenvue (NYSE:KVUE) and PURPLE INNOVATION (NASDAQ:PRPL)
04:32am, Wednesday, 29'th Oct 2025
Kenvue (NYSE: KVUE - Get Free Report) and PURPLE INNOVATION (NASDAQ: PRPL - Get Free Report) are both consumer staples companies, but which is the better investment? We will compare the two businesses
Embattled Tylenol Maker Kenvue Hires New Marketing Chief
03:23pm, Tuesday, 28'th Oct 2025
The company plans to name snack food executive Jon Halvorson as it faces a crisis over concerns of links between Tylenol and autism.
Texas sues J&J and Kenvue, claiming they hid Tylenol's autism risks
09:13am, Tuesday, 28'th Oct 2025
The makers of Tylenol, Johnson & Johnson and Kenvue , were sued on Tuesday by Texas Attorney General Ken Paxton, who accused them of knowingly hiding the drug's links to autism and attention deficit h
Texas sued Tylenol maker Kenvue, alleging it deceived pregnant women about risks associated with autism
08:39am, Tuesday, 28'th Oct 2025
The suit alleges that the Tylenol maker engaged in deceptive marketing by advertising the product as safe to use while pregnant.
